239 related articles for article (PubMed ID: 36524236)
1. Comparing the Characteristics of Microglia Preparations Generated Using Different Human iPSC-Based Differentiation Methods to Model Neurodegenerative Diseases.
Tang YM; Pulimood NS; Stifani S
ASN Neuro; 2022; 14():17590914221145105. PubMed ID: 36524236
[TBL] [Abstract][Full Text] [Related]
2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
3. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
Haenseler W; Rajendran L
Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
[TBL] [Abstract][Full Text] [Related]
4. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
Okano H; Morimoto S
Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
[TBL] [Abstract][Full Text] [Related]
5. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
6. Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia.
Funes S; Jung J; Gadd DH; Mosqueda M; Zhong J; Shankaracharya ; Unger M; Stallworth K; Cameron D; Rotunno MS; Dawes P; Fowler-Magaw M; Keagle PJ; McDonough JA; Boopathy S; Sena-Esteves M; Nickerson JA; Lutz C; Skarnes WC; Lim ET; Schafer DP; Massi F; Landers JE; Bosco DA
Nat Commun; 2024 Mar; 15(1):2497. PubMed ID: 38509062
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration.
Ramaswami G; Yuva-Aydemir Y; Akerberg B; Matthews B; Williams J; Golczer G; Huang J; Al Abdullatif A; Huh D; Burkly LC; Engle SJ; Grossman I; Sehgal A; Sigova AA; Fremeau RT; Liu Y; Bumcrot D
Sci Rep; 2024 Jan; 14(1):2153. PubMed ID: 38272949
[TBL] [Abstract][Full Text] [Related]
8. Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro.
Dolan MJ; Therrien M; Jereb S; Kamath T; Gazestani V; Atkeson T; Marsh SE; Goeva A; Lojek NM; Murphy S; White CM; Joung J; Liu B; Limone F; Eggan K; Hacohen N; Bernstein BE; Glass CK; Leinonen V; Blurton-Jones M; Zhang F; Epstein CB; Macosko EZ; Stevens B
Nat Immunol; 2023 Aug; 24(8):1382-1390. PubMed ID: 37500887
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia.
Washer SJ; Perez-Alcantara M; Chen Y; Steer J; James WS; Trynka G; Bassett AR; Cowley SA
Sci Rep; 2022 Nov; 12(1):19454. PubMed ID: 36376339
[TBL] [Abstract][Full Text] [Related]
10. ALS, a cellular whodunit on motor neuron degeneration.
Karagiannis P; Inoue H
Mol Cell Neurosci; 2020 Sep; 107():103524. PubMed ID: 32629110
[TBL] [Abstract][Full Text] [Related]
11. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.
Giacomelli E; Vahsen BF; Calder EL; Xu Y; Scaber J; Gray E; Dafinca R; Talbot K; Studer L
Cell Stem Cell; 2022 Jan; 29(1):11-35. PubMed ID: 34995492
[TBL] [Abstract][Full Text] [Related]
12. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a simplified method to generate human microglia from pluripotent stem cells.
McQuade A; Coburn M; Tu CH; Hasselmann J; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2018 Dec; 13(1):67. PubMed ID: 30577865
[TBL] [Abstract][Full Text] [Related]
14. Modeling ALS and FTD with iPSC-derived neurons.
Lee S; Huang EJ
Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
[TBL] [Abstract][Full Text] [Related]
15. Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.
Nikel LM; Talbot K; Vahsen BF
Bioessays; 2024 May; ():e2400054. PubMed ID: 38713169
[TBL] [Abstract][Full Text] [Related]
16. Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms.
Sabogal-Guáqueta AM; Marmolejo-Garza A; de Pádua VP; Eggen B; Boddeke E; Dolga AM
Prog Neurobiol; 2020 Jul; 190():101805. PubMed ID: 32335273
[TBL] [Abstract][Full Text] [Related]
17. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression.
Quek H; Cuní-López C; Stewart R; Colletti T; Notaro A; Nguyen TH; Sun Y; Guo CC; Lupton MK; Roberts TL; Lim YC; Oikari LE; La Bella V; White AR
J Neuroinflammation; 2022 Feb; 19(1):58. PubMed ID: 35227277
[TBL] [Abstract][Full Text] [Related]
18. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
[TBL] [Abstract][Full Text] [Related]
19. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
20. Modeling Alzheimer's disease with iPSC-derived brain cells.
Penney J; Ralvenius WT; Tsai LH
Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
